Baltimore-based AgeneBio announced a pair of grants from the National Institutes of Health that will assist with clinical trials of a…
Super UserOctober 15, 2018
MaxCyte announced the first patient has been dosed in its Phase I dose-escalation clinical trial in the United States with…
Super UserOctober 15, 2018
However long a business has operated, investors will look for three big things if they are going to invest.
Super UserOctober 15, 2018
U.S. healthcare companies have collected $23.4 billion in venture capital funding this year — already surpassing the amount the sector…
Super UserOctober 15, 2018
The number of open innovation challenges in pharma grows by the day. But what’s driving them? That’s what Luminary Labs…
Super UserOctober 15, 2018
The first Biohealth Capital Region Investment Conference kicks off this week in Montgomery County. The conference marks an important inflection…
Super UserOctober 15, 2018
Europe’s biotech industry recently celebrated its growth and progress with more than 120 events taking place across 18 European countries…
Super UserOctober 15, 2018
Biopharma venture capital activity maintained its red-hot pace during the third quarter of 2018, driven by a handful of deals…
Super UserOctober 15, 2018
This has been a year marked by many notable biotech deals, especially in the immunotherapy market. One deal, in particular,…
Super UserOctober 15, 2018